Tap to Trade in Gate Square, Win up to 50 GT & Merch!
Click the trading widget in Gate Square content, complete a transaction, and take home 50 GT, Position Experience Vouchers, or exclusive Spring Festival merchandise.
Click the registration link to join
https://www.gate.com/questionnaire/7401
Enter Gate Square daily and click any trading pair or trading card within the content to complete a transaction. The top 10 users by trading volume will win GT, Gate merchandise boxes, position experience vouchers, and more.
The top prize: 50 GT.
 disclosed two insider transactions. Director Malenka Robert C. sold 7,039 shares on February 3, 2026.
【Recent Insider Transactions】
【Company Information】
MapLight Therapeutics, Inc. was incorporated in November 2018 under Delaware law. The company is a clinical-stage biopharmaceutical company focused on improving the lives of patients with degenerative central nervous system (CNS) diseases. The company aims to address the lack of targeted drug therapies for specific neural circuits in patients. Its discovery platform is designed to identify causal neural circuits related to disease and to develop therapeutic modulation of these circuits. Its lead candidate, ML-007C-MA, is a fixed-dose combination intended to treat psychosis caused by schizophrenia and Alzheimer’s disease, aiming to activate specific muscarinic receptors in the central nervous system while minimizing peripheral side effects.